FDA Primer: An Overview Of FDA's Regulation Of Biotech And Practical, Near-Term Implications For Entrepreneurs

Thursday, February 10, 2005

Crowell & Moring
1001 Pennsylvania Aveneu, NW
Washington, DC

Topics discussed will include various aspects of the Investigational and New Drug Application (IND/NDA) process, marketing approval for devices, cost-effective advice from consultants and others and common early stage FDA-related mistakes. Event begins at 6:00 pm with a light supper. Registration begins January 10th